These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16363057)

  • 1. Cidofovir incorporation into human keratinocytes with episomal HPV 16 results in nonselective cytotoxicity.
    Spanos WC; El-Deiry M; Lee JH
    Ann Otol Rhinol Laryngol; 2005 Nov; 114(11):840-6. PubMed ID: 16363057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis.
    Donne AJ; Hampson L; He XT; Rothera MP; Homer JJ; Hampson IN
    Head Neck; 2007 Aug; 29(8):741-50. PubMed ID: 17252592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms.
    Mertens B; Nogueira T; Stranska R; Naesens L; Andrei G; Snoeck R
    Oncotarget; 2016 Jul; 7(30):47302-47318. PubMed ID: 27331622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha interferon augments cidofovir's antiviral and antiproliferative activities.
    Johnson JA; Gangemi JD
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2022-6. PubMed ID: 12760891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
    Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage.
    De Schutter T; Andrei G; Topalis D; Naesens L; Snoeck R
    BMC Med Genomics; 2013 May; 6():18. PubMed ID: 23702334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.
    Sirianni N; Wang J; Ferris RL
    Oral Oncol; 2005 Apr; 41(4):423-8. PubMed ID: 15792615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cidofovir induces an increase in levels of low-risk and high-risk HPV E6.
    Donne AJ; Hampson L; He XT; Rothera MP; Homer JJ; Hampson IN
    Head Neck; 2009 Jul; 31(7):893-901. PubMed ID: 19283851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro.
    Hostetler KY; Rought S; Aldern KA; Trahan J; Beadle JR; Corbeil J
    Mol Cancer Ther; 2006 Jan; 5(1):156-9. PubMed ID: 16432174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells.
    Andrei G; Snoeck R; Schols D; De Clercq E
    Oncol Res; 2000; 12(9-10):397-408. PubMed ID: 11697818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of HPV DNA copy number in cidofovir therapy of recurrent respiratory papillomatosis.
    Major T; Sziklai I; Czeglédy J; Gáll T; Gergely L; Szarka K
    Anticancer Res; 2008; 28(4B):2169-74. PubMed ID: 18751391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
    Johnson JA; Gangemi JD
    Antimicrob Agents Chemother; 1999 May; 43(5):1198-205. PubMed ID: 10223936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
    Abdulkarim B; Sabri S; Deutsch E; Chagraoui H; Maggiorella L; Thierry J; Eschwege F; Vainchenker W; Chouaïb S; Bourhis J
    Oncogene; 2002 Apr; 21(15):2334-46. PubMed ID: 11948417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
    Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
    Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
    Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
    Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
    Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
    J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts.
    Deberne M; Levy A; Mondini M; Dessen P; Vivet S; Supiramaniam A; Vozenin MC; Deutsch E
    Anticancer Drugs; 2013 Jul; 24(6):599-608. PubMed ID: 23698251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.
    Wakisaka N; Yoshizaki T; Raab-Traub N; Pagano JS
    Int J Cancer; 2005 Sep; 116(4):640-5. PubMed ID: 15818619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration.
    Lace MJ; Anson JR; Haugen TH; Dierdorff JM; Turek LP
    Carcinogenesis; 2015 Jan; 36(1):151-9. PubMed ID: 25416558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.